Vital Farms Shares Decline Following TD Cowen Downgrade
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy VITL?
Source: seekingalpha
- Downgrade Impact: TD Cowen downgraded Vital Farms from Buy to Hold and slashed the price target by 36% to $16 per share, causing the stock to spend nearly the entire day in negative territory, reflecting market concerns about the company's future performance.
- Sales Trend Slowdown: The analyst noted that the slowdown in VITL's retail sales trends has already led to a contraction in the stock's valuation multiple, while elevated short interest indicates investor caution regarding the company's outlook.
- Divergent Market Sentiment: While Wall Street remains mostly bullish on Vital Farms, viewing it as a Strong Buy, Seeking Alpha's Quant score gives it a low rating of 1.09, indicating significant weaknesses in momentum and revisions, highlighting market disagreement on its growth prospects.
- Uncertain Future Outlook: The analyst stated that they will remain on the sidelines until there is more clarity on whether the causes of the sales slowdown are transitory or enduring, which may impact investor confidence and the stock's short-term trajectory.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VITL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VITL
Wall Street analysts forecast VITL stock price to rise
12 Analyst Rating
11 Buy
0 Hold
1 Sell
Strong Buy
Current: 13.550
Low
44.00
Averages
48.90
High
60.00
Current: 13.550
Low
44.00
Averages
48.90
High
60.00
About VITL
Vital Farms, Inc. offers a range of ethically produced foods nationwide. The Company is a national consumer brand that works with more than 575 family farms and is the United States brand of pasture-raised eggs. The Company focuses on the humane treatment of farm animals and sustainable farming practices. The Company packages, markets and distributes shell eggs, butter, and other products. Its products, including shell eggs, butter, hard-boiled eggs, and liquid whole eggs, are sold in approximately 23,500 stores nationwide. The retail varieties of its shell eggs are based on supplemental feed type, egg size, and pack size. Its egg packaging consists primarily of corrugated boxes and egg cartons. The Company offers unsalted and sea-salted varieties of its butter, which are sold in two-stick and four-stick packs. The Company’s products are principally sold under the name Vital Farms in addition to other trade names, primarily to retail and foodservice channels in the United States.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Downgrade Impact: TD Cowen downgraded Vital Farms from Buy to Hold and slashed the price target by 36% to $16 per share, causing the stock to spend nearly the entire day in negative territory, reflecting market concerns about the company's future performance.
- Sales Trend Slowdown: The analyst noted that the slowdown in VITL's retail sales trends has already led to a contraction in the stock's valuation multiple, while elevated short interest indicates investor caution regarding the company's outlook.
- Divergent Market Sentiment: While Wall Street remains mostly bullish on Vital Farms, viewing it as a Strong Buy, Seeking Alpha's Quant score gives it a low rating of 1.09, indicating significant weaknesses in momentum and revisions, highlighting market disagreement on its growth prospects.
- Uncertain Future Outlook: The analyst stated that they will remain on the sidelines until there is more clarity on whether the causes of the sales slowdown are transitory or enduring, which may impact investor confidence and the stock's short-term trajectory.
See More

Company Overview: Vital Farms has made significant changes to its financial outlook, indicating a shift in strategy.
Target Price Adjustment: The target price for Vital Farms' stock has been reduced from $25 to $16, reflecting a more conservative market assessment.
See More
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, to participate in the class action and potentially receive compensation without any out-of-pocket fees.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in rolling out its new ERP system, which led to missing its full-year 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
- Investor Guidance: Investors are advised to select counsel with a proven track record to represent them, avoiding firms that merely act as intermediaries, ensuring they receive the best legal support and resources during litigation.
See More
- Class Action Initiated: Wolf Haldenstein Adler Freeman & Herz LLP has announced a class action lawsuit on behalf of investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, with a deadline of May 26, 2026, for investors to apply as lead plaintiffs, indicating significant investor dissatisfaction with the company's financial performance.
- Poor Financial Performance: Vital Farms' 10-K report filed on February 26, 2026, revealed a revenue of $759.44 million for fiscal year 2025, falling short of the $775 million guidance, while the reported earnings per share (EPS) of $0.35 also missed the market consensus of $0.39, highlighting challenges in financial management.
- ERP System Impact: The report indicated that the company faced temporary disruptions in order and fulfillment levels following the launch of a new ERP system, which may have contributed to the revenue and earnings decline, exacerbating investor concerns about operational efficiency.
- Significant Stock Price Drop: Following the earnings report, Vital Farms' stock price plummeted from $24.79 on February 25, 2026, to $22.11, representing an approximate 11% decline, reflecting a substantial decrease in market confidence regarding the company's future prospects.
See More
- Lawsuit Background: Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, has filed a class action lawsuit against Vital Farms (NASDAQ: VITL) and certain officers, seeking damages for investors who purchased securities between May 8, 2025, and February 26, 2026.
- Allegations: The complaint alleges that Vital Farms downplayed the risks associated with delays in rolling out its new ERP system and failed to disclose the impact of these delays, which caused the company to miss its full-year 2025 earnings guidance and consensus EPS, misleading investors.
- Investor Action: Affected investors are encouraged to apply to be lead plaintiffs by May 26, 2026, to share in any potential recovery, with the option to participate without needing to serve as lead plaintiff.
- Law Firm's Strength: Bronstein, Gewirtz & Grossman, LLC is renowned for representing investors in securities fraud class actions, having recovered hundreds of millions for investors nationwide, emphasizing its commitment to restoring investor capital and ensuring corporate accountability.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms (NASDAQ: VITL) securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, to represent other investors in the class action lawsuit.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in rolling out its new enterprise resource planning (ERP) system, failing to disclose the impact of these delays on its 2025 full-year earnings guidance and earnings per share consensus, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked No. 1 by ISS Securities Class Action Services in 2017, showcasing its strong capabilities and successful track record in this field.
- Investor Selection Advice: Investors are advised to carefully choose law firms with proven success in leadership roles, avoiding firms that merely act as intermediaries, to ensure effective legal representation and support in the class action.
See More










